Tried Multiple Tinnitus Treatments With No Results? A Research-Based Audit

If you have tried multiple tinnitus treatments with no meaningful improvement, published research offers a clear explanation: most treatments that fail do so because they were mismatched to the tinnitus profile, applied for too short a duration, or missing an evidence-based pairing. You have not run out of options. This article audits each major treatment category against what clinical trials actually found.

If you've tried multiple tinnitus treatments without meaningful improvement, published research offers several potential explanations. Most treatments that don't produce results were either mismatched to the specific tinnitus profile, applied for insufficient duration, or used in isolation when evidence supports combination approaches. This article reviews what the published literature says about each major treatment category — what it found, what it didn't find, and what the limitations were. Whether the research context changes what you should try next is a question for your audiologist or tinnitus specialist.

Why does tinnitus treatment have a poor reputation?

The published literature offers a clear structural answer: the tinnitus treatment field has historically been fragmented, with most interventions studied in isolation, over short durations, and without adequate control for tinnitus subtype.

A second clinical reality: published trial evidence for most tinnitus interventions focuses on 3–6 month outcomes. Research in chronic tinnitus suggests that neurological habituation — the process by which a persistent signal loses its perceived importance — typically requires 12–24 months. Treatments assessed at 6 weeks may not have been given a sufficient timeframe.

The treatment with the most consistent published evidence across multiple randomised controlled trials — CBT-based tinnitus therapy — is the least commercially visible and requires professional referral rather than product purchase. Many people reach it last, if at all.

An evidence audit: what does research actually say about each treatment?

Supplements (ginkgo, zinc, magnesium, B vitamins)

A systematic review and meta-analysis found no consistent evidence that ginkgo biloba reduces tinnitus severity compared to placebo in randomised controlled trials (Rejali et al., 2004).¹ Similar reviews of zinc and magnesium supplementation have not produced consistent positive findings.

Published clinical guidelines for tinnitus (Tunkel et al., 2014, American Academy of Otolaryngology) specifically recommend against recommending these supplements as treatments for persistent tinnitus, citing the lack of evidence.²

Supplements are not harmful in most populations at standard doses. The published evidence does not support them as a primary treatment. Whether supplements are appropriate as a complement to other management is a question to discuss with your clinician.

Hearing aids

Published clinical guidelines support hearing aids for tinnitus management specifically in people with confirmed hearing loss (Tunkel et al., 2014).² The mechanism is amplification of ambient sound, reducing the perceptual contrast that makes tinnitus noticeable.

Research also shows that hearing aids do not eliminate tinnitus for everyone — many people with hearing loss continue to perceive their tinnitus even with well-fitted devices. The same guidelines do not support hearing aids for tinnitus in people with normal or near-normal hearing. If hearing aids were recommended without a confirmed audiometric finding, the published evidence would not predict benefit. This does not mean other treatments won't help — it means that particular intervention may have been mismatched to the clinical presentation. Whether a hearing aid evaluation is appropriate for your situation is for your audiologist to determine.

Sound therapy and masking

A 2012 Cochrane systematic review of sound-based tinnitus therapies examined six trials involving 553 participants (Hobson, Chisholm, & El Refaie).³ The review found limited evidence and no significant change in tinnitus loudness or overall severity across the trials examined. The authors noted that this absence of strong evidence should not be interpreted as proof of ineffectiveness, and that methodological limitations in the available studies make conclusions difficult.

A clinical distinction the research draws: there is a difference between masking (playing sound louder than tinnitus to cover it) and sound enrichment (playing background sound softer than tinnitus to reduce perceived contrast). The Cochrane review primarily examined masking devices. Sound enrichment is used differently in clinical practice — as a component of broader management programmes rather than as a standalone treatment. Whether either approach is appropriate for your situation is a clinical decision.

ENT consultation

ENT clinicians are the appropriate first referral for assessing new-onset tinnitus. Published guidelines recommend that ENT evaluation focuses on ruling out medically treatable causes: acoustic neuroma, otosclerosis, vascular abnormalities, Ménière's disease, sudden sensorineural hearing loss, and medication-induced tinnitus (Tunkel et al., 2014).²

For idiopathic tinnitus — where no structural or treatable cause is identified — the ENT role is diagnostic, not therapeutic. Published guidelines explicitly recommend that ENTs refer patients to audiologists and psychological support for evidence-based tinnitus management, rather than concluding the consultation at "nothing we can do."

If an ENT found no treatable cause and did not connect you to a tinnitus audiologist or CBT pathway, published guidelines suggest the clinical pathway was incomplete — not a reflection of whether treatment options exist.

Tinnitus Retraining Therapy (TRT)

TRT is a structured combination of directive counselling (explaining the neurophysiological model of tinnitus) and extended sound enrichment. A Cochrane review of TRT trials (Phillips & McFerran, 2010) found that available evidence did not allow firm conclusions about superiority over other management approaches, due to methodological limitations in the trials examined.⁴ The review did not find evidence that TRT is harmful.

Research on TRT notes that it requires qualified clinician involvement for the counselling component — provision of a sound generator alone does not constitute TRT. TRT is typically implemented over 12–18 months. Whether TRT is appropriate for your situation is for your tinnitus clinician to advise.

CBT-based tinnitus therapy

A randomised controlled trial published in The Lancet (Cima et al., 2012) enrolled 492 patients randomised to specialised CBT-based care versus usual care.⁵ The CBT group showed significantly greater reduction in tinnitus-related disability on the Tinnitus Questionnaire, with effects maintained at 12 months. Importantly, the treatment did not change tinnitus loudness on audiological testing — it reduced the distress, sleep impact, and functional intrusion.

A 2011 RCT in Behaviour Research and Therapy (Westin et al.) compared Acceptance and Commitment Therapy (ACT) with Tinnitus Retraining Therapy, finding that 54.5% of ACT participants showed reliable improvement on the primary outcome at 6 months versus 20% in the TRT group.⁶ (Note: "reliable improvement" refers to a change score exceeding the reliable change index on the primary tinnitus impact measure — not a complete resolution.)

Published tinnitus guidelines (Tunkel et al., 2014) recommend CBT as the intervention with the strongest evidence for tinnitus management.² If CBT has not been part of your treatment history, your GP or audiologist can advise on referral pathways.

Bimodal neuromodulation (Lenire)

The TENT-A1 trial (Conlon et al., 2020, Science Translational Medicine) enrolled 326 patients with chronic subjective tinnitus in a randomised study of a device delivering sound to the ears and mild electrical stimulation to the tongue.⁷ The trial found statistically significant reduction in tinnitus symptoms, sustained through 12-month follow-up, with high patient adherence and no serious adverse events.

Lenire is CE-marked and FDA-cleared. It requires prescription through a licensed audiologist and is not appropriate for all tinnitus profiles — the TENT-A1 study enrolled patients with tinnitus duration over 6 months and no severe hearing loss. Whether Lenire is appropriate for your specific presentation is a decision for your audiologist.

What symptoms require immediate medical evaluation?

These presentations require medical investigation to rule out vascular and structural causes. Please seek medical attention before reading further about management options if any of these apply.

How is treatment success measured in clinical research?

Research trials for tinnitus do not use tinnitus loudness as the primary outcome measure. Published studies consistently show that tinnitus loudness, as measured by audiological matching, rarely changes significantly even with treatments that produce substantial improvements in quality of life.

The Tinnitus Functional Index (TFI) is the validated questionnaire used as a primary outcome in major trials including Cima 2012. It measures impact across sleep, concentration, emotional distress, and daily function. In published research, a reduction of 13 points or more on the TFI over 6–12 months is defined as a clinically meaningful change.

Taking a TFI baseline before starting any new approach gives you and your clinician a reference point. Without a baseline, it is difficult to assess whether anything is working — particularly for treatments that operate gradually over months. Free TFI assessment at silenear.com →

What does research say about long-term prognosis?

Published follow-up data from tinnitus cohorts show heterogeneous outcomes. A proportion of people with long-standing tinnitus achieve full habituation — the sound becomes genuinely background and rarely noticed. A larger proportion achieve meaningful improvement in quality-of-life measures without the tinnitus disappearing. A subset experience persistent significant distress despite evidence-based treatment.

Research also consistently shows that the longer high-distress tinnitus goes without structured management, the harder habituation becomes — which is one argument for engaging with the evidence base rather than repeated trials of unproven approaches.

If you have been told "learn to live with it" without a structured management pathway, published clinical guidelines (Tunkel et al., 2014) describe that as an inadequate clinical response.² Asking specifically for a tinnitus specialist referral — an audiologist with tinnitus specialisation, or a clinical psychologist trained in CBT for tinnitus — is supported by those guidelines.